The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point-of-care Infectious Disease Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The global Point-of-care Infectious Disease Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Point-of-care Infectious Disease Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Assisted Living Healthcare Facilities, are propelling Point-of-care Infectious Disease Diagnostics market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clostridium Difficile POC segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point-of-care Infectious Disease Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point-of-care Infectious Disease Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point-of-care Infectious Disease Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point-of-care Infectious Disease Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point-of-care Infectious Disease Diagnostics covered in this report include Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics and OraSure Technologies, etc.
The global Point-of-care Infectious Disease Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Global Point-of-care Infectious Disease Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-care Infectious Disease Diagnostics market, Segment by Type:
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
Global Point-of-care Infectious Disease Diagnostics market, by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point-of-care Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The global Point-of-care Infectious Disease Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Point-of-care Infectious Disease Diagnostics in various end use industries. The expanding demands from the Hospitals, Clinics, Home and Assisted Living Healthcare Facilities, are propelling Point-of-care Infectious Disease Diagnostics market. HIV POC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clostridium Difficile POC segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point-of-care Infectious Disease Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point-of-care Infectious Disease Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point-of-care Infectious Disease Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point-of-care Infectious Disease Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point-of-care Infectious Disease Diagnostics covered in this report include Thermo Fisher Scientific, Abbott, Calypte Biomedical, Chembio Diagnostic Systems, Meridian Bioscience, MedMira, Trinity Biotech, Sekisui Diagnostics and OraSure Technologies, etc.
The global Point-of-care Infectious Disease Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Global Point-of-care Infectious Disease Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-care Infectious Disease Diagnostics market, Segment by Type:
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
Global Point-of-care Infectious Disease Diagnostics market, by Application
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point-of-care Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point-of-care Infectious Disease Diagnostics
1.1 Point-of-care Infectious Disease Diagnostics Market Overview
1.1.1 Point-of-care Infectious Disease Diagnostics Product Scope
1.1.2 Point-of-care Infectious Disease Diagnostics Market Status and Outlook
1.2 Global Point-of-care Infectious Disease Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2029)
1.4 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
1.6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
1.6.2 Europe Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
1.6.4 Latin America Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size (2018-2029)
2 Point-of-care Infectious Disease Diagnostics Market by Type
2.1 Introduction
2.1.1 HIV POC
2.1.2 Clostridium Difficile POC
2.1.3 HBV POC
2.1.4 Respiratory Syncytial Virus POC
2.1.5 HPV POC
2.1.6 Influenza/Flu POC
2.1.7 HCV POC
2.1.8 MRSA POC
2.1.9 TB and Drug-Resistant TB POC
2.2 Global Point-of-care Infectious Disease Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Type (2018-2029)
3 Point-of-care Infectious Disease Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Home
3.1.4 Assisted Living Healthcare Facilities
3.1.5 Laboratories
3.1.6 Others
3.2 Global Point-of-care Infectious Disease Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point-of-care Infectious Disease Diagnostics Revenue Breakdown by Application (2018-2029)
4 Point-of-care Infectious Disease Diagnostics Competition Analysis by Players
4.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2022)
4.3 Date of Key Players Enter into Point-of-care Infectious Disease Diagnostics Market
4.4 Global Top Players Point-of-care Infectious Disease Diagnostics Headquarters and Area Served
4.5 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Point-of-care Infectious Disease Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.2.4 Abbott Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Calypte Biomedical
5.3.1 Calypte Biomedical Profile
5.3.2 Calypte Biomedical Main Business
5.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.3.4 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Chembio Diagnostic Systems Recent Developments
5.4 Chembio Diagnostic Systems
5.4.1 Chembio Diagnostic Systems Profile
5.4.2 Chembio Diagnostic Systems Main Business
5.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.4.4 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Chembio Diagnostic Systems Recent Developments
5.5 Meridian Bioscience
5.5.1 Meridian Bioscience Profile
5.5.2 Meridian Bioscience Main Business
5.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.5.4 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Meridian Bioscience Recent Developments
5.6 MedMira
5.6.1 MedMira Profile
5.6.2 MedMira Main Business
5.6.3 MedMira Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.6.4 MedMira Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 MedMira Recent Developments
5.7 Trinity Biotech
5.7.1 Trinity Biotech Profile
5.7.2 Trinity Biotech Main Business
5.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.7.4 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Trinity Biotech Recent Developments
5.8 Sekisui Diagnostics
5.8.1 Sekisui Diagnostics Profile
5.8.2 Sekisui Diagnostics Main Business
5.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.8.4 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Sekisui Diagnostics Recent Developments
5.9 OraSure Technologies
5.9.1 OraSure Technologies Profile
5.9.2 OraSure Technologies Main Business
5.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.9.4 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 OraSure Technologies Recent Developments
5.10 Quidel
5.10.1 Quidel Profile
5.10.2 Quidel Main Business
5.10.3 Quidel Point-of-care Infectious Disease Diagnostics Products, Services and Solutions
5.10.4 Quidel Point-of-care Infectious Disease Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Quidel Recent Developments
6 North America
6.1 North America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Infectious Disease Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point-of-care Infectious Disease Diagnostics Market Dynamics
11.1 Point-of-care Infectious Disease Diagnostics Industry Trends
11.2 Point-of-care Infectious Disease Diagnostics Market Drivers
11.3 Point-of-care Infectious Disease Diagnostics Market Challenges
11.4 Point-of-care Infectious Disease Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
